Lisa Lancaster Archives
New drugs approved to fight idiopathic pulmonary fibrosis
Jan. 15, 2015—The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).
Study examines sleep apnea’s role in lung diseases
Apr. 13, 2012—Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases.
Lung disorder drug regimen found harmful
Oct. 31, 2011—Longtime treatment for IPF ineffective and even dangerous.